Login / Signup

Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.

Christopher Paul FilsonFangxin HongNiya XiongRachel PozzarBarbara HalpennyDonna L Berry
Published in: Cancer (2020)
Among men in a trial assessing a decision support tool, Black race and restricted treatment options were associated with less use of active surveillance for low-risk prostate cancer. Although the P3P instrument ameliorates decisional conflict, its use was not associated with more appropriate alignment of treatment with disease risk.
Keyphrases
  • prostate cancer
  • clinical trial
  • randomized controlled trial
  • study protocol
  • combination therapy
  • phase ii
  • open label